The Norwegian Research Council recently announced four large investments in biomedical research for a total of 255 MNOK.
Out of the total, 60 MNOK will go to to sequencing and precision medicine, 80 MNOK to national biobanks, 65 MNOK to brain research and 50 MNOK to Norwegian Clinical Research Infrastructure Network.
“This is great news. Biomedical research affects not only a nation’s health, but international competitiveness too,” says Ketil F. Widerberg, General Manager in Oslo Cancer Cluster in a statement
Source: Oslo Cancer Cluster